According to Enzo Biochem's latest financial reports the company's current EPS (TTM) is -$0.42. In 2019 the company made an earnings per share (EPS) of $0.02000 an increase over its 2018 EPS that were of -$0.33.
Year | EPS | Change |
---|---|---|
2022 (TTM) | -$0.42 | |
2019 | $0.02000 | -106.06% |
2018 | -$0.33 | 1018.34% |
2017 | -$0.02951 | -103.47% |
2016 | $0.85 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Quest Diagnostics
DGX | $10.36 | -2,566.67% | ๐บ๐ธ USA |
![]() LabCorp LH | $18.87 | -4,592.86% | ๐บ๐ธ USA |
![]() RadNet RDNT | $0.13 | -130.95% | ๐บ๐ธ USA |
![]() Psychemedics PMD | -$0.36 | -14.26% | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | -$1.32 | 214.29% | ๐บ๐ธ USA |
![]() Qiagen QGEN | $1.85 | -540.51% | ๐ณ๐ฑ Netherlands |